Post-election jitters have struck pharma after a surprise result for the UK. With Brexit on the horizon and a minority government in charge, has the industry’s optimism been dashed?
Featuring: The UK election and Pharma - Brexit and the EMA's relocation - The future of the Pharma-CRO relationship
With Brexit negotiations beginning, Catalyst Corporate Finance’s Tom Cowap argues that Britain's divorce from the EU could actually give a major boost to the UK’s pharma sector
Wearables are here to stay – and pharma shouldn't ignore this golden opportunity
The National Institute for Health and Care Excellence (NICE) is now backing routine NHS commissioning of Teva’s Cinqaero to treat a severe form of asthma after having initially been minded to block the drug’s use.
21st July 2017
European regulators have approved Vifor Pharma’s new potassium binder Veltassa to treat hyperkalaemia in adult patients.
21st July 2017
The US Food and Drug Administration has given a tentative green light to Merck & Co’s follow-on biologic basal insulin Lusduna Nexvue.
21st July 2017
Sanofi has signed a research pact and licensing deal with Ablynx that could bring as much as $2.7 billion euros to the Belgian biotech’s coffers if all targets are met.
21st July 2017
If the answer is yes, take the first step toward getting your hands on the coveted Pharma by entering your Commercial Cross Functional Team into Marketer of the Year, today!
21st July 2017
Joseph B. Laudano, vice president, medical affairs strategy for Medmeme, takes a look at advances in data mining and metrics analysis
In a world of increasingly complex pharma supply chains, technology is playing a growing role in helping smooth the relationship between businesses and their suppliers
A detailed look at the ongoing patent case for Pfizer’s pain drug and what the potentially-landmark ruling could mean for the industry
With Brexit negotiations beginning, Catalyst Corporate Finance’s Tom Cowap argues that Britain's divorce from the EU could actually give a major boost to the UK’s pharma sector
Post-election jitters have struck pharma after a surprise result for the UK. With Brexit on the horizon and a minority government in charge, has the industry’s optimism been dashed?
Sue Thomas, Paul Midgley and Steve How, of Wilmington Healthcare, explain how pharma can work with the NHS to transform services
Improving the care of diabetes patients at City Hospitals Sunderland - a joint working initiative with Lilly
Engaging digital while retaining a human touch
Sanofi’s general manager for the UK and Ireland Hugo Fry on leading a company through transitional times
Richard Baderin, head of commercial enterprises at Accretio, on making the most of your resources
Laurence Woollard talks to PharmaTimes about life with a rare bleeding disorder
The pharmaceutical supply chain is facing both challenges and opportunities as the industry enters a new healthcare era 26 PharmaTimes
Across all industries, people are changing the ways they engage with products, services, and brands. View more...
Wednesday, 28 September 2016 - 11:00 am
George Underwood
FREE - Listen again now - | VIEW NOW
